Crilly A, Hamilton J, Clark C J, Jardine A, Madhok R
Department of Medicine, Glasgow Royal Infirmary, Glasgow, UK.
Rheumatology (Oxford). 2003 Nov;42(11):1295-8. doi: 10.1093/rheumatology/keg420. Epub 2003 Jul 16.
Fibrosis, a feature of systemic sclerosis (SSc), is more severe in the diffuse compared with the limited disease variant. Interleukin 10 (IL-10) is an anti-inflammatory cytokine which reduces type 1 collagen mRNA levels in human fibroblasts. The 5' flanking region of the IL-10 gene is highly polymorphic, with three single base pair substitutions at position -1082(G/A), -819(C/T) and -592(C/A), which results in differential IL-10 production. The GCC/GCC genotype is associated with high IL-10 production while the ATA/ATA genotype with low production. We postulated that there would be a difference in IL-10 polymorphisms in patients with limited (lSSc) and diffuse (dSSc) disease.
Patients with limited (lSSc, n = 89) or diffuse (dSSc, n = 51) disease plus controls (n = 94) were recruited. DNA was isolated from peripheral blood and polymorphisms analysed using amplification refractory mutation system (ARMS) polymerase chain reaction (PCR).
dSSc patients were less likely to carry the genotype indicative of high IL-10 production when compared with controls (controls vs dSSc; 29 vs 4%, chi2 = 15.7, 5 df, P = 0.005) and lSSc patients (lSSc vs dSSc; 21 vs 4%, chi2 = 17.5, 5 df, P = 0.002). There was no difference between control and lSSc patients. While there was no difference between controls and lSSc haplotypes, the GCC haplotype distribution did differ significantly between controls and dSSc patients (controls vs dSSc; 54 vs 36%, chi2 = 11.2, 2 df, P = 0.001). A significant difference was also observed between lSSc and dSSc haplotype distribution (lSSc vs dSSc; 48 vs 36%, chi2 = 13.5, 2 df, P < 0.001).
We demonstrate that IL-10 genotypes associated with high IL-10 production are under-represented in dSSc. This may have implications in the disease pathology.
纤维化是系统性硬化症(SSc)的一个特征,与局限性疾病变体相比,弥漫性疾病中的纤维化更为严重。白细胞介素10(IL-10)是一种抗炎细胞因子,可降低人成纤维细胞中I型胶原蛋白mRNA水平。IL-10基因的5'侧翼区域具有高度多态性,在-1082(G/A)、-819(C/T)和-592(C/A)位置有三个单碱基对替换,这导致IL-10产生存在差异。GCC/GCC基因型与高IL-10产生相关,而ATA/ATA基因型与低产生相关。我们推测局限性(lSSc)和弥漫性(dSSc)疾病患者的IL-10多态性会存在差异。
招募了局限性(lSSc,n = 89)或弥漫性(dSSc,n = 51)疾病患者以及对照组(n = 94)。从外周血中分离DNA,并使用扩增不应突变系统(ARMS)聚合酶链反应(PCR)分析多态性。
与对照组(对照组与dSSc;29%对4%,χ2 = 15.7,5自由度,P = 0.005)和lSSc患者(lSSc与dSSc;21%对4%,χ2 = 17.5,5自由度,P = 0.002)相比,dSSc患者携带指示高IL-10产生的基因型的可能性较小。对照组和lSSc患者之间没有差异。虽然对照组和lSSc单倍型之间没有差异,但对照组和dSSc患者之间的GCC单倍型分布确实存在显著差异(对照组与dSSc;54%对36%,χ2 = 11.2,2自由度,P = 0.001)。lSSc和dSSc单倍型分布之间也观察到显著差异(lSSc与dSSc;48%对36%,χ2 = 13.5,2自由度,P < 0.001)。
我们证明与高IL-10产生相关的IL-10基因型在dSSc中代表性不足。这可能对疾病病理学有影响。